The University of Chicago Header Logo

Connection

Rex C. Haydon to Piperazines

Back to Details
This is a "connection" page, showing publications Rex C. Haydon has written about Piperazines.
Rex C. Haydon
Connection Strength
0.264
Piperazines
  1. Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy. Cancer Biol Ther. 2004 Apr; 3(4):393-4.
    View in: PubMed
    Score: 0.214
  2. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.